VXRT
Vaxart Inc
0.44$
-2.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 57.1% | 37.0% | 50.4% | 17.2% | – | 7.2% | – | – | – | 21.8% | – | – | – | |
| 42.9% | 63.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 714.0% | 453.2% | 871.8% | 273.1% | 305.4% | 149.2% | 147.3% | 125.2% | 104.9% | 43.3% | 75.0% | 124.2% | 75.8% | |
| 234.2% | 167.6% | 331.9% | 80.9% | 88.0% | 26.5% | 24.3% | 11.6% | 5.9% | 3.5% | 11.8% | 24.3% | 7.9% | |
| 891.1% | 583.8% | 1,203.6% | 354.0% | 393.4% | 175.7% | 171.5% | 136.8% | 110.8% | 46.8% | 86.8% | 148.5% | 83.7% | |
| -848.3% | -520.8% | -1,103.6% | -254.0% | -293.4% | -75.7% | -71.5% | -36.8% | -10.8% | 53.2% | 13.2% | -48.5% | 16.3% | |
| 9.9% | 26.9% | 36.9% | 9.5% | 12.8% | 6.1% | 4.8% | 1.7% | 0.8% | 0.5% | 1.3% | 2.0% | 0.9% | |
| -826.3% | -530.1% | -1,117.5% | -256.9% | -285.1% | -77.8% | -74.2% | -37.7% | -11.2% | 53.1% | 13.3% | -49.5% | 16.0% | |
| 1.9% | 5.4% | 2.1% | 0.3% | 0.4% | 1.2% | 0.5% | 0.1% | 0.0% | 0.3% | 0.1% | 0.1% | 0.2% | |
| -828.2% | -535.4% | -1,119.5% | -257.2% | -285.4% | -78.9% | -74.7% | -37.7% | -11.2% | 52.8% | 13.2% | -49.6% | 15.9% | |
| -759.4% | -466.2% | -980.8% | -212.8% | -227.2% | -57.0% | -58.7% | -30.4% | -7.5% | 55.6% | 17.4% | -44.8% | 19.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.